Indian benchmark indices closed in the green on Thursday for the second straight day, driven by domestic investors buying ...

Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use. This marks Qiagen’s second ...

Interrupted access to the data has already led to worse outcomes and could undermine faith in the U.S. healthcare system, ...

First-in-human global studies initiated for ZW191, an antibody-drug conjugate (ADC) engineered to target folate receptor-? (FR?) and ZW171, a bispecific 2 + 1 T cell engager (TCE) targeting mesothelin ...

VOQUEZNA® (vonoprazan) generated $55.3 million in 2024 net revenues in its first full year of launch, driven by strong demand, including $29.7 million in Q4, an 81% increase from Q3Over 300,000 filled ...

Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on March 1, 2025 the Company granted ...

"But between January and February, we have seen an upsurge in the reports that we did," Mr Ogbonna said.The National Human Rights Commission (NHRC), on Wednesday, reported a spike in rape incidents ...

Jamshedpur: In a proactive move to ensure food safety during the upcoming festive season, Deputy Commissioner Ananya Mittal ...